206 related articles for article (PubMed ID: 30628466)
1. Conducting clinical trials-costs, impacts, and the value of clinical trials networks: A scoping review.
Bentley C; Cressman S; van der Hoek K; Arts K; Dancey J; Peacock S
Clin Trials; 2019 Apr; 16(2):183-193. PubMed ID: 30628466
[TBL] [Abstract][Full Text] [Related]
2. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
3. American Society of Clinical Oncology policy statement: oversight of clinical research.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
[TBL] [Abstract][Full Text] [Related]
4. Funding oncology clinical trials: are cooperative group trials sustainable?
Seow HY; Whelan P; Levine MN; Cowan K; Lysakowski B; Kowaleski B; Snider A; Xu RY; Arnold A
J Clin Oncol; 2012 May; 30(13):1456-61. PubMed ID: 22454412
[TBL] [Abstract][Full Text] [Related]
5. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
[TBL] [Abstract][Full Text] [Related]
6. Health economics in clinical research.
Manns BJ
Methods Mol Biol; 2015; 1281():315-30. PubMed ID: 25694319
[TBL] [Abstract][Full Text] [Related]
7. Economic benefits of sponsored clinical trials on pharmaceutical expenditures at a medical center in Taiwan.
Shen LJ; Chou H; Huang CF; Chou GM; Chan WK; Wu FL
Contemp Clin Trials; 2011 Jul; 32(4):485-91. PubMed ID: 21530679
[TBL] [Abstract][Full Text] [Related]
8. Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.
Sullivan SD; Mauskopf JA; Augustovski F; Jaime Caro J; Lee KM; Minchin M; Orlewska E; Penna P; Rodriguez Barrios JM; Shau WY
Value Health; 2014; 17(1):5-14. PubMed ID: 24438712
[TBL] [Abstract][Full Text] [Related]
9. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
Allen D; Rixson L
Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
[TBL] [Abstract][Full Text] [Related]
10. Criteria for site selection in industry-sponsored clinical trials: a survey among decision-makers in biopharmaceutical companies and clinical research organizations.
Dombernowsky T; Haedersdal M; Lassen U; Thomsen SF
Trials; 2019 Dec; 20(1):708. PubMed ID: 31829234
[TBL] [Abstract][Full Text] [Related]
11. Telemedicine for the Medicare population: pediatric, obstetric, and clinician-indirect home interventions.
Hersh WR; Wallace JA; Patterson PK; Shapiro SE; Kraemer DF; Eilers GM; Chan BK; Greenlick MR; Helfand M
Evid Rep Technol Assess (Summ); 2001 Aug; (24 Suppl):1-32. PubMed ID: 11569328
[TBL] [Abstract][Full Text] [Related]
12. A review of methods used in long-term cost-effectiveness models of diabetes mellitus treatment.
Tarride JE; Hopkins R; Blackhouse G; Bowen JM; Bischof M; Von Keyserlingk C; O'Reilly D; Xie F; Goeree R
Pharmacoeconomics; 2010; 28(4):255-77. PubMed ID: 20222752
[TBL] [Abstract][Full Text] [Related]
13. Generalisability in economic evaluation studies in healthcare: a review and case studies.
Sculpher MJ; Pang FS; Manca A; Drummond MF; Golder S; Urdahl H; Davies LM; Eastwood A
Health Technol Assess; 2004 Dec; 8(49):iii-iv, 1-192. PubMed ID: 15544708
[TBL] [Abstract][Full Text] [Related]
14. Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation.
Dündar Y; Boland A; Strobl J; Dodd S; Haycox A; Bagust A; Bogg J; Dickson R; Walley T
Health Technol Assess; 2004 Jun; 8(24):iii-x, 1-125. PubMed ID: 15193209
[TBL] [Abstract][Full Text] [Related]
15. Measuring research impact in Australia's medical research institutes: a scoping literature review of the objectives for and an assessment of the capabilities of research impact assessment frameworks.
Deeming S; Searles A; Reeves P; Nilsson M
Health Res Policy Syst; 2017 Mar; 15(1):22. PubMed ID: 28327199
[TBL] [Abstract][Full Text] [Related]
16. A systematic review of on-site monitoring methods for health-care randomised controlled trials.
Macefield RC; Beswick AD; Blazeby JM; Lane JA
Clin Trials; 2013 Feb; 10(1):104-24. PubMed ID: 23345308
[TBL] [Abstract][Full Text] [Related]
17. Intersectoral Costs and Benefits of Mental and Behavioural Disorders in the Education Sector: an Exploration of Costing Methods.
Bremmers LGM; Evers SMAA; Drost RMWA; Janssen LMM; Pokhilenko I; Paulus ATG; Norton EC; Yoon J; Cuddeback GS; Morrissey JP
J Ment Health Policy Econ; 2020 Sep; 23(3):115-137. PubMed ID: 33411675
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
